Prot# IST000362: A Single-Center Proof of Concept Pilot Study to Evaluate the Safety, Efficacy, and Tolerability of Sorafenib Combined with Theraspheres in Subjects with Hepatocellular Carcinoma Awaiting Liver Transplantation

Project: Research project

Project Details

StatusFinished
Effective start/end date8/12/08 → 3/31/13

Funding

  • Bayer HealthCare Pharmaceuticals, Inc. (IST000362)